Journal for ImmunoTherapy of Cancer (Jul 2020)

Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1–mediated immunoescape via STING-IFN signaling and extracellular vesicles

  • Tsung-Hsien Chuang,
  • An Ning Cheng,
  • Li-Chun Cheng,
  • Cheng-Liang Kuo,
  • Yu Kang Lo,
  • Han-Yu Chou,
  • Chung-Hsing Chen,
  • Yi-Hao Wang,
  • Shih-Jung Cheng,
  • Alan Yueh-Luen Lee

DOI
https://doi.org/10.1136/jitc-2020-001372
Journal volume & issue
Vol. 8, no. 2

Abstract

Read online

Background Mitochondrial Lon is a chaperone and DNA-binding protein that functions in protein quality control and stress response pathways. The level of Lon regulates mitochondrial DNA (mtDNA) metabolism and the production of mitochondrial reactive oxygen species (ROS). However, there is little information in detail on how mitochondrial Lon regulates ROS-dependent cancer immunoescape through mtDNA metabolism in the tumor microenvironment (TME).Methods We explored the understanding of the intricate interplay between mitochondria and the innate immune response in the inflammatory TME.Results We found that oxidized mtDNA is released into the cytosol when Lon is overexpressed and then it induces interferon (IFN) signaling via cGAS-STING-TBK1, which upregulates PD-L1 and IDO-1 expression to inhibit T-cell activation. Unexpectedly, upregulation of Lon also induces the secretion of extracellular vehicles (EVs), which carry mtDNA and PD-L1. Lon-induced EVs further induce the production of IFN and IL-6 from macrophages, which attenuates T-cell immunity in the TME.Conclusions The levels of mtDNA and PD-L1 in EVs in patients with oral cancer function as a potential diagnostic biomarker for anti-PD-L1 immunotherapy. Our studies provide an insight into the immunosuppression on mitochondrial stress and suggest a therapeutic synergy between anti-inflammation therapy and immunotherapy in cancer.